Invention Grant
- Patent Title: Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate
-
Application No.: US17874399Application Date: 2022-07-27
-
Publication No.: US12043597B2Publication Date: 2024-07-23
- Inventor: Anantha Rajmohan Muthusamy , Sundara Lakshmi Kanniah , Elluru Subbireddy
- Applicant: ASSIA CHEMICAL INDUSTRIES LTD.
- Applicant Address: IL Petach Tikva
- Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee Address: IL Petach Tikva
- Agency: Carter, DeLuca & Farrell LLP
- Priority: IN 1811033405 2018.09.05 IN 1811039438 2018.10.17 IN 1911022155 2019.06.04
- Main IPC: C07D213/82
- IPC: C07D213/82
Abstract:
The present disclosure encompasses crystalline polymorphs of Rivoceranib and Rivoceranib mesylate (Apatinib mesylate), processes for preparation thereof, and pharmaceutical compositions thereof.
Public/Granted literature
- US20220371998A1 NEW CRYSTALLINE POLYMORPHS OF RIVOCERANIB AND RIVOCERANIB MESYLATE Public/Granted day:2022-11-24
Information query
IPC分类:
